Detalhe da pesquisa
1.
Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease.
Ann Neurol
; 88(1): 183-194, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32468646
2.
Long-Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease.
Mov Disord
; 36(3): 740-749, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33215762
3.
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.
JAMA Oncol
; 9(1): 128-134, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36326731
4.
Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies.
Alzheimers Dement (N Y)
; 8(1): e12296, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35662832
5.
Alteration of Autophagy and Glial Activity in Nilotinib-Treated Huntington's Disease Patients.
Metabolites
; 12(12)2022 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36557263
6.
Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial.
JAMA Neurol
; 77(3): 309-317, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31841599
7.
Parvovirus B19-induced hemophagocytic lymphohistiocytosis: Case report and review of the literature.
Clin Case Rep
; 7(11): 2076-2081, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31788255
8.
Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease.
Pharmacol Res Perspect
; 7(2): e00470, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30906562
9.
Advances in immunotherapy for melanoma management.
Hum Vaccin Immunother
; 12(10): 2501-2511, 2016 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27454404